The Effect of Aging on Quality of Life in Acromegaly Patients Under Treatment

ContextWith the increasing number of older patients with acromegaly, it is important to understand the effects of aging on the quality of life (QoL) in acromegaly.ObjectiveTo investigate the factors associated with the QoL of older acromegaly patients.DesignThis was a single-center, retrospective, c...

Full description

Bibliographic Details
Main Authors: Naoki Yamamoto, Shin Urai, Hidenori Fukuoka, Masaaki Yamamoto, Kenichi Yoshida, Masaki Suzuki, Hiroki Shichi, Yasunori Fujita, Keitaro Kanie, Genzo Iguchi, Yutaka Takahashi, Wataru Ogawa
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.819330/full
_version_ 1818509821413949440
author Naoki Yamamoto
Shin Urai
Hidenori Fukuoka
Masaaki Yamamoto
Kenichi Yoshida
Masaki Suzuki
Hiroki Shichi
Yasunori Fujita
Keitaro Kanie
Genzo Iguchi
Genzo Iguchi
Genzo Iguchi
Yutaka Takahashi
Yutaka Takahashi
Wataru Ogawa
author_facet Naoki Yamamoto
Shin Urai
Hidenori Fukuoka
Masaaki Yamamoto
Kenichi Yoshida
Masaki Suzuki
Hiroki Shichi
Yasunori Fujita
Keitaro Kanie
Genzo Iguchi
Genzo Iguchi
Genzo Iguchi
Yutaka Takahashi
Yutaka Takahashi
Wataru Ogawa
author_sort Naoki Yamamoto
collection DOAJ
description ContextWith the increasing number of older patients with acromegaly, it is important to understand the effects of aging on the quality of life (QoL) in acromegaly.ObjectiveTo investigate the factors associated with the QoL of older acromegaly patients.DesignThis was a single-center, retrospective, cross-sectional study conducted between 2014 and 2019.MethodsAmong 90 acromegaly patients at Kobe University Hospital, 74 who had completed the QoL evaluation under treatment were enrolled (age = 62.0 [50.7–70.0], female 52%). SF-36 and the AcroQoL questionnaire were used to quantify QoL. The patients were divided into two groups: the young and middle-aged group, aged <65 years (51.0 [46.0–59.2], n =42), and the older group, aged ≥65 years (70.5 [69.0–73.0], n =32). The factors associated with the QoL scores were analyzed using univariate and multivariate regression analyses.ResultsThe scores for the physical component summary of SF-36 were negatively associated with age (P <0.01), while those for the mental or role/social component summary were positively associated (P <0.01, P =0.03, respectively). In contrast, AcroQoL scores were not associated with age. However, the different factors were associated with lower AcroQoL scores; arthropathy and higher BMI in the older group (P <0.01, and P =0.01, respectively), and treatment modalities and size of pituitary tumor in the young and middle-aged group (P <0.01, P =0.04, respectively). Replacement of hydrocortisone was commonly associated both in young and middle-aged group (P =0.04), and in older group (P =0.02).ConclusionWe showed that the factors associated with impaired QoL differed in the young and middle-aged, and older patients with acromegaly. In older patients, arthropathy and higher BMI were associated with poor QoL. These suggest the importance of early diagnosis and appropriate treatment in preventing arthropathy in acromegaly.
first_indexed 2024-12-10T22:50:41Z
format Article
id doaj.art-a1fe217b88d946a9b8f31c2c59f6c91a
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-10T22:50:41Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-a1fe217b88d946a9b8f31c2c59f6c91a2022-12-22T01:30:26ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-02-011310.3389/fendo.2022.819330819330The Effect of Aging on Quality of Life in Acromegaly Patients Under TreatmentNaoki Yamamoto0Shin Urai1Hidenori Fukuoka2Masaaki Yamamoto3Kenichi Yoshida4Masaki Suzuki5Hiroki Shichi6Yasunori Fujita7Keitaro Kanie8Genzo Iguchi9Genzo Iguchi10Genzo Iguchi11Yutaka Takahashi12Yutaka Takahashi13Wataru Ogawa14Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, JapanDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, JapanDivision of Diabetes and Endocrinology, Kobe University Hospital, Kobe, JapanDivision of Diabetes and Endocrinology, Kobe University Hospital, Kobe, JapanDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, JapanDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, JapanDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, JapanDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, JapanDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, JapanDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, JapanMedical Center for Student Health, Kobe University, Kobe, JapanDepartment of Biosignal Pathophysiology, Kobe University Graduate School of Medicine, Kobe, JapanDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, JapanDepartment of Diabetes and Endocrinology, Nara Medical University, Kashihara, JapanDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, JapanContextWith the increasing number of older patients with acromegaly, it is important to understand the effects of aging on the quality of life (QoL) in acromegaly.ObjectiveTo investigate the factors associated with the QoL of older acromegaly patients.DesignThis was a single-center, retrospective, cross-sectional study conducted between 2014 and 2019.MethodsAmong 90 acromegaly patients at Kobe University Hospital, 74 who had completed the QoL evaluation under treatment were enrolled (age = 62.0 [50.7–70.0], female 52%). SF-36 and the AcroQoL questionnaire were used to quantify QoL. The patients were divided into two groups: the young and middle-aged group, aged <65 years (51.0 [46.0–59.2], n =42), and the older group, aged ≥65 years (70.5 [69.0–73.0], n =32). The factors associated with the QoL scores were analyzed using univariate and multivariate regression analyses.ResultsThe scores for the physical component summary of SF-36 were negatively associated with age (P <0.01), while those for the mental or role/social component summary were positively associated (P <0.01, P =0.03, respectively). In contrast, AcroQoL scores were not associated with age. However, the different factors were associated with lower AcroQoL scores; arthropathy and higher BMI in the older group (P <0.01, and P =0.01, respectively), and treatment modalities and size of pituitary tumor in the young and middle-aged group (P <0.01, P =0.04, respectively). Replacement of hydrocortisone was commonly associated both in young and middle-aged group (P =0.04), and in older group (P =0.02).ConclusionWe showed that the factors associated with impaired QoL differed in the young and middle-aged, and older patients with acromegaly. In older patients, arthropathy and higher BMI were associated with poor QoL. These suggest the importance of early diagnosis and appropriate treatment in preventing arthropathy in acromegaly.https://www.frontiersin.org/articles/10.3389/fendo.2022.819330/fullacromegalyquality of lifearthropathyolder patientsAcroQoL
spellingShingle Naoki Yamamoto
Shin Urai
Hidenori Fukuoka
Masaaki Yamamoto
Kenichi Yoshida
Masaki Suzuki
Hiroki Shichi
Yasunori Fujita
Keitaro Kanie
Genzo Iguchi
Genzo Iguchi
Genzo Iguchi
Yutaka Takahashi
Yutaka Takahashi
Wataru Ogawa
The Effect of Aging on Quality of Life in Acromegaly Patients Under Treatment
Frontiers in Endocrinology
acromegaly
quality of life
arthropathy
older patients
AcroQoL
title The Effect of Aging on Quality of Life in Acromegaly Patients Under Treatment
title_full The Effect of Aging on Quality of Life in Acromegaly Patients Under Treatment
title_fullStr The Effect of Aging on Quality of Life in Acromegaly Patients Under Treatment
title_full_unstemmed The Effect of Aging on Quality of Life in Acromegaly Patients Under Treatment
title_short The Effect of Aging on Quality of Life in Acromegaly Patients Under Treatment
title_sort effect of aging on quality of life in acromegaly patients under treatment
topic acromegaly
quality of life
arthropathy
older patients
AcroQoL
url https://www.frontiersin.org/articles/10.3389/fendo.2022.819330/full
work_keys_str_mv AT naokiyamamoto theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT shinurai theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT hidenorifukuoka theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT masaakiyamamoto theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT kenichiyoshida theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT masakisuzuki theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT hirokishichi theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT yasunorifujita theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT keitarokanie theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT genzoiguchi theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT genzoiguchi theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT genzoiguchi theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT yutakatakahashi theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT yutakatakahashi theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT wataruogawa theeffectofagingonqualityoflifeinacromegalypatientsundertreatment
AT naokiyamamoto effectofagingonqualityoflifeinacromegalypatientsundertreatment
AT shinurai effectofagingonqualityoflifeinacromegalypatientsundertreatment
AT hidenorifukuoka effectofagingonqualityoflifeinacromegalypatientsundertreatment
AT masaakiyamamoto effectofagingonqualityoflifeinacromegalypatientsundertreatment
AT kenichiyoshida effectofagingonqualityoflifeinacromegalypatientsundertreatment
AT masakisuzuki effectofagingonqualityoflifeinacromegalypatientsundertreatment
AT hirokishichi effectofagingonqualityoflifeinacromegalypatientsundertreatment
AT yasunorifujita effectofagingonqualityoflifeinacromegalypatientsundertreatment
AT keitarokanie effectofagingonqualityoflifeinacromegalypatientsundertreatment
AT genzoiguchi effectofagingonqualityoflifeinacromegalypatientsundertreatment
AT genzoiguchi effectofagingonqualityoflifeinacromegalypatientsundertreatment
AT genzoiguchi effectofagingonqualityoflifeinacromegalypatientsundertreatment
AT yutakatakahashi effectofagingonqualityoflifeinacromegalypatientsundertreatment
AT yutakatakahashi effectofagingonqualityoflifeinacromegalypatientsundertreatment
AT wataruogawa effectofagingonqualityoflifeinacromegalypatientsundertreatment